[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$ftC7r6ekNTgqjCV8wTEBLtr0upBC1K7BOmZtA_AVNKZY":8,"$fJ4i-vQUfQstUgGjEltERTcu0rq1gltyMvqgILMGDJBg":55,"$fNX0Rjwx9mbnNVxWI0KgI6MmZo9JfPtKmM2xtZZDamsk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},46056,863402,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//0Rvlsm1tdkSbq5L99bjhchaojzwJ5kCw.png","华晓萍","浙江大学医学院附属妇产科医院","妇科","主治医师",94,0,"卵巢癌IC2期治疗用药：BEP化疗方案实用安全指南","","https://ystcdn.venuertc.com/venue/AI/8ebae1e3-b34b-4a63-a6d5-a6e05838e03b.jpg","\u003Cdiv class=\"bep-guide-wrap\">\n\n  \u003Cdiv class=\"bep-title-section\" id=\"material_title\">\n    \u003Ch2 class=\"bep-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">卵巢癌IC2期治疗用药：BEP化疗方案实用安全指南\u003C/h2>\n    \u003Cp class=\"bep-intro\">\n      化疗药物的正确使用关乎疗效与安全。BEP方案（顺铂+依托泊苷+博来霉素）作为经典化疗组合被广泛用于手术后辅助治疗。本文将结合临床实际与权威资料，为大家梳理BEP方案涉及的主要药品、止吐药和辅助药的用法、注意事项等12个必知细节，并融入典型用药案例，让安全高效用药成为每个人都能掌握的常识。🌿\n    \u003C/p>\n  \u003C/div>\n\n  \u003C!-- 方案组成与基本机制 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to right, #e0ece9 0%, #f7fafc 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 BEP化疗方案三药成分与机制简介\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>顺铂（Cisplatin）：\u003C/strong> 属铂类抗肿瘤药，通过与DNA结合损伤肿瘤细胞遗传物质，阻止细胞分裂和增殖。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>依托泊苷（Etoposide）：\u003C/strong> 属植物源性抗肿瘤药，可抑制DNA拓扑异构酶II，诱导癌细胞凋亡。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>博来霉素（Bleomycin）：\u003C/strong> 以抗生素类结构切断肿瘤细胞DNA链，增强细胞杀伤效果。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-data-tip\">\n        \u003Cspan>📊 \u003C/span>\n        临床指南推荐II期及以上分期需完成4个周期BEP化疗，每种药物的排布需严格遵守专家共识。\n      \u003C/div>\n      \u003Cdiv class=\"bep-ref\">\u003Cem>参考文献：\u003C/em> Ledermann, J.A., et al. (2014). \"Chemotherapy for ovarian cancer.\" \u003Cem>Annals of Oncology\u003C/em>, 25(Suppl 3), iii24–iii32.\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 用药方式及时间安排 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to left, #f6f3ff 0%, #e9effa 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 化疗药的用法用量与给药顺序\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>BEP方案给药日程：\u003C/strong>连续5天静脉输注依托泊苷+顺铂，博来霉素一般在第1、8、15天各用一次，整个化疗周期为21天。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>剂量调整：\u003C/strong>具体剂量应根据医生评估患者体表面积、肝肾功能制定，治疗过程中若出现白细胞、血小板降低等，需动态调整。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>输液配伍要求：\u003C/strong>顺铂不宜和铝制表面接触。所有药物应严格遵照静脉点滴速率，防止血管刺激。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-case-highlight\">\n        \u003Cspan>🩺\u003C/span>\n        一位31岁女性，分两次住院完成两周期BEP，用药期间严格遵医嘱调整化疗间隔，有效降低了骨髓抑制风险。\n      \u003C/div>\n      \u003Cdiv class=\"bep-ref\">\u003Cem>参考文献：\u003C/em> Pectasides, D., et al. (2004). \"Bleomycin, etoposide and cisplatin chemotherapy for germ cell tumors.\" \u003Cem>Annals of Oncology\u003C/em>, 15(7), 1157–1170.\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 剂型及特殊操作要求 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to right, #f9faf2 0%, #e0e9ec 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 剂型说明与使用技巧\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>顺铂：\u003C/strong>以注射液为主，仅供静脉滴注。需大量补液，严禁皮下注射或肌肉注射。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>依托泊苷：\u003C/strong>注射液或口服胶囊（国内常用静脉制剂），滴注时间通常1-2小时以上，口服者需在餐后服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>博来霉素：\u003C/strong>注射用冻干粉，用生理盐水溶解后静脉推注或肌注，避免皮下渗漏，防止局部组织反应。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-note\">\n        \u003Cstrong>正确做法：\u003C/strong>每次配药前核对剂型，严格避光输注，防止药液降解，减少疗效损失。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 药物相互作用注意点 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to left, #f3f6fb 0%, #eef9f0 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 化疗药物之间以及其他药品的相互作用\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          顺铂与氨基苷类抗生素或利尿药合用时，肾毒性风险升高，应避免叠加使用。\n        \u003C/li>\n        \u003Cli>\n          依托泊苷与华法林等抗凝药合用会干扰凝血功能，易增加出血概率。\n        \u003C/li>\n        \u003Cli>\n          博来霉素联合胸腔放疗会增强肺毒性，应避开同一疗程内叠加使用。\n        \u003C/li>\n        \u003Cli>\n          口服制剂如阿奇霉素、奥美拉唑等部分药品也会影响BEP药物代谢，使用新药前务必与主管医生沟通。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-caution\">\n        \u003Cspan>⚠️\u003C/span>\n        正确做法：每次化疗前后需申报所有正在服用的药品，避免因药物相互作用导致不良事件。\n      \u003C/div>\n      \u003Cdiv class=\"bep-ref\">\u003Cem>引用：\u003C/em> Basch, E., et al. (2011). \"Clinical practice guidelines for antiemetics.\" \u003Cem>Journal of Clinical Oncology\u003C/em>, 29(31), 4189–4198.\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 用药禁忌与特殊人群 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to right, #fcf8ed 0%, #eaf2e0 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 适应人群与禁忌症说明\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>BEP方案一般适用：\u003C/strong>成年女性，体能状况良好，肝肾功能可耐受化疗。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>禁忌：\u003C/strong>\n          \u003Cul>\n            \u003Cli>\n              严重肝功能、肾功能损害者，不能耐受顺铂和依托泊苷。\n            \u003C/li>\n            \u003Cli>\n              既往有博来霉素或铂类药物严重过敏史者禁用。\n            \u003C/li>\n            \u003Cli>\n              孕期及哺乳期女性，化疗药品可导致胎儿和婴儿不良反应，禁用。\n            \u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>特殊提醒：\u003C/strong>肺功能异常者或曾接受胸部放疗患者，慎用博来霉素。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 止吐及辅助治疗药物的使用指导 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to left, #eff7fa 0%, #fef6ef 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 化疗相关止吐及辅助药物合理搭配（真实用药案例）\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>昂丹司琼口溶膜：\u003C/strong>常于化疗开始前30分钟口服，主要预防急性化疗相关恶心呕吐。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>盐酸阿扎司琼氯化钠注射液：\u003C/strong>和其他止吐药协同支持，溶解后静脉滴注，主要起延迟止吐作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助：\u003C/strong>谷胱甘肽（护肝支持），兰索拉唑（胃酸抑制），氨基酸注射液（营养补充）原则上与化疗药物错峰用药。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-case2\">\n        \u003Cspan>👩🏼‍⚕️\u003C/span> \n        实际案例：一名31岁已婚已育女性，术后BEP化疗期间因恶心呕吐显著，通过昂丹司琼和阿扎司琼联合用药大幅缓解不适，顺利完成两周期化疗。\n      \u003C/div>\n      \u003Cdiv class=\"bep-note\">\n        \u003Cstrong>正确做法：\u003C/strong>每个周期前后留意恶心控制，必要时与医生沟通调整止吐药物组合。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 常见不良反应与处理 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to right, #f2fafd 0%, #faf4ec 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 化疗常见不良反应及应对方法\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>顺铂：\u003C/strong>易致肾损伤、耳毒性和恶心呕吐；化疗期间必须大量补液促进排泄。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>依托泊苷：\u003C/strong>常见骨髓抑制（白细胞、血小板降低）、轻度脱发。化疗前后监测血常规。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>博来霉素：\u003C/strong>肺纤维化风险，表现为咳嗽、气急。用药期间每周期评估肺功能。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-bold-tip\">\n        正确做法：一旦出现持续发热、呼吸困难、明显出血倾向，立即就医检查，切勿自行处理。\n      \u003C/div>\n      \u003Cdiv class=\"bep-ref\">\u003Cem>参考文献：\u003C/em> O'Shaughnessy, J. (2003). \"Chemotherapy-induced nausea and vomiting: strategies for prevention and treatment.\" \u003Cem>Oncology (Williston Park)\u003C/em>, 17(9), 1359–1370.\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 合理储存与药物保存细则 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to left, #f9faf1 0%, #e4eef5 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 药品储存要求和开封管理\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          顺铂、依托泊苷溶液需避光密闭保存于2-8℃冰箱内，开封后建议12小时内使用完毕。\u003C/li>\n        \u003Cli>\n          博来霉素冻干粉需干燥存放，避开高温潮湿，溶解后4小时内应输注完毕。\n        \u003C/li>\n        \u003Cli>\n          昂丹司琼、阿扎司琼等止吐制剂常温避光保存即可，注意防潮。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-note\">\n        \u003Cstrong>正确做法：\u003C/strong>家用药柜区分存放化疗药和辅助药，明确药品有效期，过期药妥善交医废处理。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 用药漏服与过量应对 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to right, #faf9fc 0%, #eaf8ec 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 若忘记或误服BEP方案药物怎么办？\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          化疗药必须在专业医护人员监督下按计划实施，若漏服或过量应立即报告主治医生，严禁自行补用或延长疗程。\n        \u003C/li>\n        \u003Cli>\n          止吐药如昂丹司琼、阿扎司琼漏服，可待下个剂量按常规服用，不建议双倍服药。\n        \u003C/li>\n        \u003Cli>\n          化疗期间一旦自觉中毒（如大量呕吐、乏力、昏迷），必须第一时间前往医院急诊。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-caution\">\n        \u003Cspan>❗️\u003C/span>\n        正确做法：化疗全程避免自行更改药量，一切调整请遵医嘱。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 特殊人群用药说明 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to left, #f5faee 0%, #f6f9fd 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 老年人、特殊人群的用药调整建议\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          年龄&体重较低患者，化疗前需测定肾功能、肝功能，如有异常酌情调整剂量，部分药物可下调10-20%。\n        \u003C/li>\n        \u003Cli>\n          身体合并多种基础药品时，务必将所有药品清单提交医生，避免相互作用。\n        \u003C/li>\n        \u003Cli>\n          孕妇、哺乳期女性禁用BEP方案药物，用药期间建议采取有效避孕措施。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-ref\">\u003Cem>参考文献：\u003C/em> McGuire, W.P., et al. (1996). \"Chemotherapy for Advanced Ovarian Cancer: 10-Year Follow-Up.\" \u003Cem>New England Journal of Medicine\u003C/em>, 334(1), 1–6.\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 日常监测和自我管理要点 -->\n  \u003Csection class=\"bep-section\" style=\"background-image: linear-gradient(to right, #eefaf4 0%, #e9f3fc 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 化疗期间日常监测与自我管理\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>\n          每周期化疗前检查血常规、肝肾功能、心电图、肺功能。\n        \u003C/li>\n        \u003Cli>\n          保持饮食清淡，足量饮水，减少高盐高脂食物摄入，可帮助减少呕吐和肾脏负担。\n        \u003C/li>\n        \u003Cli>\n          用药期间不可随意服新药，有任何不适立即向医生反馈。\n        \u003C/li>\n        \u003Cli>\n          重视口腔、皮肤护理，防治感染和局部黏膜溃疡。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-note\">\n        \u003Cstrong>正确做法：\u003C/strong>配合每周期化疗同步监测体重、尿量，发现异常及时联系医生，避免因副反应被耽误治疗。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 结语与核心提示 -->\n  \u003Csection class=\"bep-section bep-summary\" style=\"background-image: linear-gradient(to left, #fffcef 0%, #eef9fb 100%);\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">12 化疗期间安全用药的核心要点总结\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Cul>\n        \u003Cli>BEP三药须分步正确配制和给药，不可混淆操作流程。\u003C/li>\n        \u003Cli>全程监控用药反应，恶心呕吐可通过多种止吐药切换调整，副作用一旦严重停止下一步化疗并及时就医。\u003C/li>\n        \u003Cli>储存方式要求冰箱避光，家中妥善分区，过期药品绝不继续使用。\u003C/li>\n        \u003Cli>所有用药和电解质、营养补液均听从专业医师和药师安排，绝不能私自增加或缩短方案。\u003C/li>\n        \u003Cli>完成每周期后务必做好自我管理和健康跟进，加强与医护团队沟通。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"bep-final-box\">\n        安全用药细节决定疗效与生活品质。只要掌握规范流程，让每一次化疗都安心、无忧。遇到任何新药、特殊状况，请随时征询医生意见。🌸\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 引用文献及参考资料 -->\n  \u003Csection class=\"bep-section bep-ref-list\" style=\"background-color: #f8fafb;\">\n    \u003Ch2 class=\"bep-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">引用文献 References\u003C/h2>\n    \u003Cdiv class=\"bep-section-content\">\n      \u003Col>\n        \u003Cli>\n          Ledermann, J.A., Raja, F.A., Fotopoulou, C., et al. (2014). Chemotherapy for ovarian cancer. \u003Cem>Annals of Oncology\u003C/em>, 25(Suppl 3), iii24–iii32. https://doi.org/10.1093/annonc/mdu385\n        \u003C/li>\n        \u003Cli>\n          Pectasides, D., et al. (2004). Bleomycin, etoposide and cisplatin chemotherapy for germ cell tumors. \u003Cem>Annals of Oncology\u003C/em>, 15(7), 1157–1170. https://doi.org/10.1093/annonc/mdh294\n        \u003C/li>\n        \u003Cli>\n          Basch, E., et al. (2011). Antiemetics: American Society of Clinical Oncology clinical practice guideline update. \u003Cem>Journal of Clinical Oncology\u003C/em>, 29(31), 4189–4198. https://doi.org/10.1200/JCO.2010.34.4614\n        \u003C/li>\n        \u003Cli>\n          McGuire, W.P., Hoskins, W.J., Brady, M.F., et al. (1996). Chemotherapy for Advanced Ovarian Cancer: 10-Year Follow-Up. \u003Cem>New England Journal of Medicine\u003C/em>, 334(1), 1–6. https://doi.org/10.1056/NEJM199601043340101\n        \u003C/li>\n        \u003Cli>\n          O'Shaughnessy, J. (2003). Chemotherapy-induced nausea and vomiting: strategies for prevention and treatment. \u003Cem>Oncology (Williston Park)\u003C/em>, 17(9), 1359–1370.\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/section>\n\n\u003C/div>\n\n\u003Cstyle>\n.bep-guide-wrap {\n  max-width: 890px;\n  margin: 32px auto;\n  font-family: 'Helvetica Neue', Arial, 'PingFang SC', 'Microsoft YaHei', sans-serif;\n  color: #324147;\n  background: #f8fafb;\n  border-radius: 22px;\n  box-shadow: 0 10px 36px rgba(47, 79, 79, 0.13);\n  padding: 0 36px 46px 36px;\n}\n.bep-title-section {\n  padding: 38px 0 20px 0;\n  text-align: center;\n}\n.bep-title {\n  font-size: 38px;\n  color: #35406b;\n  font-weight: bold;\n  margin-bottom: 16px;\n  letter-spacing: 1px;\n}\n.bep-intro {\n  font-size: 17px;\n  line-height: 2.0;\n  color: #6887a3;\n}\n.bep-section {\n  margin-top: 36px;\n  padding: 32px 32px 20px 32px;\n  border-radius: 15px;\n  background-size: cover;\n  background-repeat: no-repeat;\n  border: 1px solid #e2eaee;\n  box-shadow: 0 2px 9px rgba(190, 205, 219, 0.10);\n}\n.bep-section-title {\n  font-size: 23px;\n  letter-spacing: 0.5px;\n  color: #26405e;\n  margin-bottom: 16px;\n  margin-top: 0;\n  font-weight: bold;\n  position: relative;\n  padding-left: 16px;\n  line-height: 1.65;\n}\n.bep-section-title:before {\n  content: '';\n  display: inline-block;\n  width: 5px;\n  height: 22px;\n  background: linear-gradient(180deg, #5dcbb5 0%, #b3bce6 85%);\n  border-radius: 2.5px;\n  position: absolute;\n  left: 0;\n  top: 7px;\n}\n.bep-section-content {\n  font-size: 17px;\n  line-height: 2.13;\n  color: #38485f;\n  margin-bottom: 6px;\n}\n.bep-section-content ul {\n  margin: 0 0 0 10px;\n  padding: 0 0 0 19px;\n}\n.bep-section-content li {\n  margin-bottom: 10px;\n}\n.bep-data-tip,\n.bep-caution,\n.bep-note,\n.bep-bold-tip {\n  background: #e5f7f2;\n  color: #225a4a;\n  border-left: 7px solid #8bc9aa;\n  border-radius: 8px;\n  padding: 12px 16px;\n  margin: 19px 0 12px 0;\n  font-size: 15px;\n  line-height: 1.85;\n}\n.bep-data-tip {\n  background: #e9f4fb;\n  color: #35577a;\n  border-left-color: #8faedb;\n}\n.bep-caution {\n  background: #fbebe6;\n  color: #af5d4c;\n  border-left-color: #f7b8a1;\n}\n.bep-note {\n  background: #f3f9e2;\n  color: #627a35;\n  border-left-color: #bada54;\n}\n.bep-bold-tip {\n  background: #fef7e0;\n  color: #ad7d20;\n  border-left-color: #fad376;\n  font-weight: bold;\n}\n.bep-case-highlight,\n.bep-case2 {\n  background: #ebe2fa;\n  color: #543e83;\n  border-left: 7px solid #b9a8ec;\n  border-radius: 8px;\n  padding: 12px 16px;\n  margin: 19px 0 12px 0;\n  font-size: 15px;\n  line-height: 1.85;\n}\n.bep-final-box {\n  color: #225a4a;\n  font-size: 19px;\n  line-height: 1.85;\n  background: #dffbef;\n  border-radius: 11px;\n  padding: 16px 24px 16px 24px;\n  margin-top: 20px;\n  border-left: 8px solid #38b490;\n  font-weight: 600;\n  letter-spacing: 1px;\n}\n.bep-summary ul {\n  margin-top: 10px;\n  margin-bottom: 10px;\n}\n\n.bep-ref {\n  color: #7488a6;\n  font-size: 15px;\n  margin-top: 12px;\n  border-left: 5px solid #abd7ef;\n  background: #f4fdff;\n  padding: 8px 13px;\n  border-radius: 8px;\n}\n.bep-ref-list {\n  margin-top: 42px;\n  background: #eaedf1 !important;\n  border: none;\n  box-shadow: none;\n}\n.bep-ref-list ol {\n  padding-left: 20px;\n  margin-top: 7px;\n}\n.bep-ref-list li {\n  margin-bottom: 10px;\n  font-size: 16px;\n  line-height: 1.9;\n  color: #44485a;\n  word-break: break-all;\n}\n\n@media (max-width: 560px) {\n  .bep-guide-wrap {\n    padding: 0 6px 28px 6px;\n  }\n  .bep-title-section {\n    padding: 18px 3px 12px 3px;\n  }\n  .bep-title {\n    font-size: 26px;\n  }\n  .bep-section {\n    padding: 16px 7px 10px 7px;\n    font-size: 15.5px;\n  }\n  .bep-section-title {\n    font-size: 18px;\n    padding-left: 10px;\n  }\n  .bep-section-title:before {\n    width: 3px;\n    height: 18px;\n    border-radius: 1.5px;\n    left: 0;\n    top: 6px;\n  }\n  .bep-section-content,\n  .bep-section-content ul {\n    font-size: 15.5px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"bep-guide-wrap\">\n\n  \u003Cdiv class=\"bep-title-section\" id=\"material_title\">\n    \u003Ch2 class=\"b",576,"2025-07-03 18:13:10","BEP化疗, 卵巢癌, 安全用药, 顺铂, 依托泊苷, 博来霉素, 化疗方案, 药物相互作用","了解BEP化疗方案的安全用药指导，掌握顺铂、依托泊苷和博来霉素的使用方法，确保女性卵巢癌患者的有效治疗和安全管理。","2025-07-04 23:48:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]